Bisalkenyl derivatives, liquid crystalline compound and liquid crystal composition
A liquid crystal compound and alkenyl technology, which is applied in the preparation of carbon-based compounds, silicon organic compounds, organic compounds, etc., can solve problems such as narrow temperature range, poor solubility, and poor appearance of liquid crystal phases
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1V2-HH-VFF(No.25) 30.0%V-BHH-VFF(No.7) 19.0%V-BBH-VFF(No.9) 15.0%3-HB-C 5.0%1V2-BEB(F,F)-C 11.0%3-HB-02 4.0%3-HB(F)TB-2 4.0%3-H2BTB-2 4.0%3-H2BTB-3 4.0%3-H2BTB-4 4.0% Embodiment 2V2-HH-VFF(No.25) 20.0%1V-BHH-VFF(No.19) 10.0%V-BBH-VFF(No.9) 6.0%3-HB-C 10.0%1V2-BEB(F,F)-C 12.0%3-HB-02 5.0%3-HHB-1 10.0%3-HHB-3 10.0%3-HB(F)TB-2 5.0%3-H2BTB-2 4.0%3-H2BTB-3 4.0%3-H2BTB-4 4.0% Embodiment 31V-BHH-VFF(No.19) 4.0%1V2-BHH-VFF(No.118) 10.0%V2-HB-C 10.0%1V2-HB-C 10.0%3-HB-C 26.0%5-HB-C 12.0%3-HB(F)-C 8.0%2-BEB-C 3.0%V2-HHB-1 8.0%3-H2BTB-2 3.0%3-H2BTB-3 3.0%3-H2BTB-4 3.0% Embodiment 4V2-HH-VFF(No.25) 9.0%1V2-BEB(F,F)-C 11.0%201-BEB(F)-C 5.0%301-BEB(F)-C 9.0%3-HB(F)-C 15.0%101-HH-3 3.0%4-BTB-02 9.0%2-HHB(F)-C 13.0%3-HHB(F)-C 14.0%3-H2BTB-2 4.0%3-H2BTB-3 4.0%3-H2BTB-4 4.0% Embodiment 51V2-BHH-VFF(No.118) 5.0%V-BHH-2VFF(No.8) 10.0%V2-HHH-VFF(No.29) 5.0%2-BB-C 5.0%2020-BB-C 4.0%101-HB-C 10.0%201-HB-C 7.0%2-BEB-C 12.0%5-PyB-F 8.0%2-PyB-2 2.0%3-PyB-2 2.0%4-PyB-2 2.0%V-HHB-1 5.0%2-PyBH-3 5.0%3-PyBH-3 5.0%4-PyBH-3 5.0%3-PyBB-F 3.0%4-PyBB-F 3.0%6-PyBB-2 2.0% Embodiment 6V2-HH-VFF(No.25) 3.0%3-PyB(F)-F 6.0%3020-BEB-C 4.0%3-BEB-C 12.0%3-DB-C 10.0%4-DB-C 10.0%3-HEB-04 8.0%4-HEB-02 6.0%5-HEB-01 6.0%3-HEB-02 5.0%5-HEB-02 4.0%3-HHB-1 6.0%3-HHEBB-C 3.0%3-HBEBB-C 3.0%10-BEB-2 5.0%4-HEB-3 3.0%5-HEB-1 3.0%6-PyB-02 3.0% Embodiment 7V2-HH-VFF(No.25) 4.0%1V-BHH-VFF(No.19) 3.0%3-HB-C 20.0%3-HHB-1 7.0%3-HHB-3 8.0%5-HEB-F 3.0%7-HEB-F 3.0%3-HHEB-F 1.0%5-HHEB-F 1.0%3-HEB-04 4.0%4-HEB-02 3.0%5-HEB-04 3.0%3-HEB-02 2.5%5-HEB-02 2.0%3-HB(F)TB-2 4.0%3-HB(F)TB-3 4.0%3-HB(F)VB-4 3.0%3-H2BTB-2 3.0%3-H2BTB-3 3.0% 3-H2BTB-4 3.0%5-HHEBB-C 2.0%3-HBEBB-C 3.0%5-HBEBB-C 3.0%3-HEBEB-F 3.0%3-HH-EMe 2.5%101-HBBH-3 2.0% Embodiment 8V-BHH-2VFF(No.8) 6.0%5-PyB(F)-F 13.0%2-HB(F)-C 10.0%3-HB(F)-C 12.0%30-BB-C 8.0%2-HHB-C 6.0%3-HHB-C 6.0%4-HHB-C 6.0%2-HHB(F)-C 5.0%3-HHB(F)-C 5.03%3-PyBB-F 7.0%4-PyBB-F 6.0%5-HBB-C 5.0%3-HB(F)EB(F)-C 5.0% Embodiment 9V2-HH-VFF(No.25) 10.0%2-BEB(F)-C 5.0%3-BEB(F)-C 7.0%4-BEB(F)-C 5.0%5-BEB(F)-C 7.0%103-HB(F)-C 6.0%3-HHEB(F)-F 5.0%4-HHEB(F)-F 5.0%5-HHEB(F)-F 10.0%2-HBEB(F)-C 5.0%3-HBEB(F)-C 5.0%4-HBEB(F)-C 5.0%5-HBEB(F)-C 5.0%3-HBTB-2 10.0%V2-HH-3 5.0%V2-HHB-1 5.0% Embodiment 10V2-HH-VFF(No.25) 15.0%1V2-BH-VFF(No.117) 5.0%V2-HB-C 3.0%4-BB-2 5.0%3-BB-C 5.0%5-BB-C 5.0%2-HB(F)-C 5.0%3-H2B-02 5.0%5-H2B-03 10.0%3-BEB-C 5.0%5-HEB-01 6.0%5-HEB-03 6.0%5-BBB-C 3.0%4-BPyB-C 3.0%4-BPyB-5 3.0%5-HB2B-4 4.0%5-HBB2B-3 4.0%V2-HH-101 3.0%1V2-HBB-3 5.0% Embodiment 11V2-HH-VFF(No.25) 5.0%V-HH-VFF(No.1) 5.0%5-H2B(F)-F 4.0%7-HB(F)-F 10.0%2-HHB(F)-F 12.0%3-HHB(F)-F 12.0%5-HHB(F)-F 12.0%2-H2HB(F)-F 12.0%3-H2HB(F)-F 6.0%5-H2HB(F)-F 12.0%2-HBB(F)-F 2.5%3-HBB(F)-F 2.5%5-HBB(F)-F 5.0% Embodiment 12V2-HH-VFF (No.25) 7.0%7-HB(F,F)-F 2.0%2-HHB(F)-F 10.0%3-HHB(F)-F 14.0%5-HHB(F)-F 14.0%2-H2HB(F)-F 4.0%3-H2HB(F)-F 2.0%5-H2HB(F)-F 4.0%3-HHB(F,F)-F 8.0%4-HHB(F,F)-F 4.0%3-H2HB(F,F)-F 6.0%4-H2HB(F,F)-F 5.0%5-H2HB(F,F)-F 5.0%3-HH2B(F,F)-F 8.0%5-HH2B(F,F)-F 7.0% Embodiment 131V2-HHH-VFF(No.41) 8.0%7-HB(F,F)-F 5.0%3-HBB(F,F)-F 5.0%5-HBB(F,F)-F 5.0%3-HHB(F,F)-F 7.0%5-HHB(F,F)-F 5.0%3-HH2B(F,F)-F 8.0%5-HH2B(F,F)-F 5.0%3-H2HB(F,F)-F 10.0%4-H2HB(F,F)-F 10.0%5-H2HB(F,F)-F 10.0%3-HHEB(F,F)-F 8.0%4-HHEB(F,F)-F 3.0%5-HHEB(F,F)-F 3.0%3-HBEB(F,F)-F 2.0%5-HBEB(F,F)-F 2.0%3-HHHB(F,F)-F 2.0%5-HH2BB(F,F)-F 2.0% Embodiment 141V2-BH-VFF(No.117) 5.0%V2-BH-VFF(No.27) 5.0%5-HB-F 2.0%7-HB(F)-F 3.0%2-HHB(F)-F 14.0%3-HHB(F)-F 14.0%5-HHB(F)-F 14.0%3-HB-02 5.0%3-HHB-F 4.0%3-HHB-1 6.0%3-HHB-3 6.0%2-HBB-F 6.0%3-HBB-F 5.0%3-HHEB-F 3.0%5-HHEB-F 3.0%3-HBEB-F 3.0%3-HHEBB-F 2.0% Embodiment 15V2-HH-VFF(No.25) 5.0%1V2-BHH-VFF(No.118) 3.0%7-HB(F,F)-F 7.0%3-HB-CL 5.0%7-HB-CL 5.0%2-BTB-01 10.0%2-HBB(F)-F 2.5%3-HBB(F)-F 2.5%5-HBB(F)-F 5.0%3-HBB(F,F)-F 7.0%5-HBB(F,F)-F 10.0%2-HHB-CL 5.0%3-HHB-CL 3.0%3-HB(F)TB-2 6.0%3-HB(F)TB-4 6.0%2-H2BTB-2 4.0%2-H2BTB-3 4.0%3-H2HB(F)-CL 4.0%5-H2HB(F)-CL 3.0%3-H2BB(F,F)-F 3.0% Embodiment 16V2-HH-VFF(No.25) 5.0%1V2-BH-VFF(No.117) 5.0%5-HB-F 10.0%6-HB-F 5.0%7-HB-F 5.0%2-HHB-OCF3 5.0%3-HHB-OCF3 5.0%5-HHB-OCF3 5.0%3-HH2B-OCF3 6.0%5-HH2B-OCF3 6.0%3-HB(F)B-3 4.0%5-HB(F)B-3 4.0%2-HBB(F)-F 10.0%3-HBB(F)-F 10.0%5-HBB(F)-F 15.0% Embodiment 17V2-HH-VFF(No.25) 6.0%V-HH-2VFF(No.116) 3.0%1V2-HH-VFF(No.37) 3.0%5-HB-F 3.0%6-HB-F 3.0%7-HB-F 3.0%3-HHB-OCF2H 7.0%5-HHB-OCF2H 7.0%3-HHB(F,F)-OCF2H 9.0%5-HHB(F,F)-OCF2H 9.0%2-HHB-OCF3 6.0%3-HHB-OCF3 6.0%4-HHB-OCF3 6.0%5-HHB-OCF3 6.0%3-HH2B(F)-F 7.0%5-HH2B(F)-F 7.0%3-HHEB(F)-F 4.0%6-HHEB(F)-F 5.0% Embodiment 18V2-HH-VFF(No.25) 15.0%3-HEB-04 23.4%4-HEB-02 17.6%5-HEB-01 17.6%3-HEB-02 14.7%5-HEB-02 11.7%TNI=67.7(℃)η=19.6(mPa·s) Embodiment 19V2-HHH-VFF(No.29) 15.0%3-HEB-04 23.4%4-HEB-02 17.6%5-HEB-01 17.6%3-HEB-02 14.7%5-HEB-02 11.7%TNI=B9.6(℃)η=25.7(mPa·s) Embodiment 20V2-HH-2VFF(No.115) 15.0%3-HEB-04 23.4%4-HEB-02 17.6%5-HEB-01 17.6%3-HEB-02 14.7%5-HEB-02 11.7%TNI=69.5(℃)η=20.5(mPa·s) Embodiment 21V2-HH-VFF(No.25) 10.0%V2-HH-2VFF(No.115) 8.0%1V2-BEB(F,F)-C 5.0%3-HB-C 25.0%1-BTB-3 5.0%3-HH-4 3.0%3-HHB-1 11.0%3-HHB-3 9.0%3-H2BTB-2 4.0%3-H2BTB-3 4.0%3-H2BTB-4 4.0%3-HB(F)TB-2 6.0%3-HB(F)TB-3 6.0%TNI=93.3(℃)η=13.9(mPa·s)Δn=0.147Vtn=2.08(V)0.8CM33 to 100,10.5μm。 Embodiment 22V2-HHH-VFF(No.29) 8.0%201-BEB(F)-C 5.0%301-BEB(F)-C 15.0%401-BEB(F)-C 13.0%501-BEB(F)-C 13.0%2-HHB(F)-C 15.0%3-HHB(F)-C 15.0%3-HB(F)TB- 24.0%3-HB(F)TB- 34.0%3-HB(F)TB- 44.0%3-HHB-01 14.0%TNI=94.5(℃)η=85.5(mPa·s)Δn=0.149Vtn=0.90(V) Embodiment 232-HH-VFF(No.25) 4.0%V2-HH-2VFF(No.115) 9.0%V2-HHH-VFF(No.29) 8.0%5-PyB-F 4.0%3-PyB (F)-F 4.0%2-BB-C 5.0%4-BB-C 4.0%5-BB-C 5.0%2-PyB-2 2.0%6-PyB-05 3.0%3-PyBB-F 6.0%4-PyBB-F 6.0%5-PyBB-F 6.0%3-HHB-1 6.0%2-H2BTB-2 4.0%2-H2BTB-3 4.0%2-H2BTB-4 5.0%3-H2BTB-2 5.0%3-H2BTB-3 5.0%3-H2BTB-4 5.0%TNI=99.4(℃)η=28.5(mPa·s)Δn=0.191Vtn=2.32(V) Embodiment 24V2-HH-VFF(No.25) 25.0%3-DB-C 10.0%4-DB-C 10.0%2-BEB-C 12.0%3-BEB-C 4.0%3-PyB(F)-F 6.0%5-HEB-02 4.0%5-HEB-5 5.0%4-HEB-5 5.0%10-BEB-2 4.0%3-HHB-1 6.0%3-HHEBB-C 3.0%3-HBEBB-C 3.0%5-HBEBB-C 3.0%TNI=67.3(℃)η=31.0(mPa·s)Δn=0.121Vtn=1.28(V) Embodiment 25V2-HH-2VFF(No.115) 4.0%3-HB-C 18.0%7-HB-C 3.0%101-HB-C 10.0%3-HB(F)-C 10.0%4-PyB-2 2.0%101-HH-3 7.0%2-BTB-01 7.0%3-HHB-1 7.0%3-HHB-F 4.0%3-HHB-01 4.0%3-HHB-3 8.0%3-H2BTB-2 3.0%3-H2BTB-3 3.0%2-PyBH-3 4.0%3-PyBH-3 3.0%3-PyBB-2 3.0%TNI=81.4(℃)η=16.9(mPa·s)Δn=0.137 Vtn=1.77(V) Embodiment 261V2-HH-VFF(No.37) 5.0%1V2-HH-2VFF(No.38) 8.0%201-BEB(F)-C 5.0%301-BEB(F)-C 12.0%501-BEB(F)-C 4.0%1V2-BEB(F,F)-C 10.0%3-HH-EMe 5.0%3-HB-02 10.0%7-HEB-F 2.0%3-HHEB-F 2.0%5-HHEB-F 2.0%3-HBEB-F 4.0%201-HBEB(F)-C 2.0%3-HB(F)EB-C 2.0%3-HBEB(F,F)-C 2.0%3-HHB-F 4.0%3-HHB-01 4.0%3-HHB-3 13.0%3-HEBEB-F 2.0%3-HEBEB-1 2.0% Embodiment 271V-HH-VFF(No.13) 5.0%1V-HH-2VFF(No.14) 5.0%V2-HHH-VFF(No.29) 8.0%201-BEB(F)-C 5.0%301-BEB(F)-C 12.0%501-BEB(F)-C 4.0%1V2-BEB(F,F)-C 15.0%3-HH-4 3.0%3-HHB-F 3.0%3-HHB-01 4.0%3-HBEB-F 4.0%3-HHEB-F 7.0%5-HHEB-F 7.0%3-H2BTB-2 4.0%3-H2BTB-3 4.0%3-H2BTB-4 4.0%3-HB(F)TB-2 5.0% Embodiment 28V2-HH-VFF(No.25) 20.0%V2-HHH-VFF(No.29) 4.0%2-BEB-C 12.0%3-BEB-C 4.0%4-BEB-C 6.0%3-HB-C 28.0%5-HEB-01 8.0%3-HEB-02 6.0%5-HEB-02 5.0%3-HHB-1 7.0%TNI=60.4(℃)η=18.2(mPa·s)Δn=0.112Vtn=1.31(V) Embodiment 291V2-HH-VFF(No.37) 5.0%1V-HH-VFF(No.13) 5.0%1V2-HH-2VFF(No.38) 5.0%1V-HH-2VFF(No.14) 5.0%2-BEB-C 10.0%5-BB-C 12.0%7-BB-C 7.0%1-BTB-3 7.0%10-BEB-5 12.0%2-HHB-1 4.0%3-HHB-F 4.0%3-HHB-1 7.0%3-HHB-01 4.0%3-HHB-3 13.0% Embodiment 30V2-HH-2VFF(No.115) 20.0%1V2-BEB(F,F)-C 6.0%3-HB-C 18.0%2-BTB-1 10.0%5-HH-VFF 10.0%1-BHH-VFF 8.0%1-BHH-2VFF 11.0%3-H2BTB-2 5.0%3-H2BTB-3 4.0%3-H2BTB-4 4.0%3-HHB-1 4.0%TNI=83.1(℃)η=11.7(mPa·s)Δn=0.132Vtn=2.10(V) Embodiment 31V2-HHH-VFF(No.29) 8.0%2-HB-C 5.0%3-HB-C 12.0%3-HB-02 15.0%2-BTB-1 3.0%3-HHB-F 4.0%3-HHB-01 5.0%3-HHB-3 14.0%3-HHEB-F 4.0%5-HHEB-F 4.0%2-HHB(F)-F 7.0%3-HHB(F)-F 7.0%5-HHB(F)-F 7.0%3-HHB(F,F)-F 5.0%TNI=103.0(℃)η=17.2(mPa·s)Δn=0.099Vtn=2.56(V) Embodiment 32V2-HH-VFF(No.25) 3.0%V2-HHH-VFF(No.29) 5.0%3-BEB(F)-C 8.0%3-HB-C 8.0%V-HB-C 8.0%1V-HB-C 8.0%3-HH-2V 14.0%3-HH-2V1 7.0%V2-HHB-1 15.0%3-HHEB-F 7.0%3-H2BTB-2 6.0%3-H2BTB-3 6.0%3-H2BTB-4 5.0%TNI=101.3(℃)η=15.2(mPa·s)Δn=0.132Vtn=2.25(V) Embodiment 33V2-HH-2VFF(No.115) 31.0%1V2-BEB(F.F)-C 12.0%3-HB-C 4.0%3-HB-02 5.5%3-HHB-1 3.5%1-BHH-VFF 20.0%3-HB(F)TB-2 4.0%3-HB(F)TB-3 4.0%3-HB(F)TB-4 4.0%3-H2BTB-2 4.0%3-H2BTB-3 4.0%3-H2BTB-4 4.0%TNI=100.4(℃)η=14.1(mPa·s)Δn=0.133Vtn=2.16(V)2.0CN to 100,10.6μm。 Embodiment 34V2-HH-VFF(No.2 5) 28.0%1V2-BEB(F,F)-C 12.0%3-HB-C 4.0%3-HB-02 5.5%3-HHB-1 8.5%1-BHH-VFF 20.0%3-HB(F)TB-2 5.0%3-HB(F)TB-3 5.0%3-H2BTB-2 4.0%3-H2BTB-3 4.0%3-H2BTB-4 4.0%TNI=100.5(℃)η=13.9(mPa·s)Δn=0.132Vtn=2.14(V)1.81CN to 100,12.3μm。 Embodiment 35
[0125] Symbolic representation of compounds The following examples relate to nematic liquid crystal compositions containing compounds of the present invention. Use Example 1 V2-HH-VFF (No.25) 30.0% V-BHH-VFF (No.7) 19.0% V-BBH-VFF (No.9) 15.0% 3-HB-C 5.0% 1V2-BEB ( F, F)-C 11.0% 3-HB-02 4.0% 3-HB(F)TB-2 4.0% 3-H2BTB-2 4.0% 3-H2BTB-3 4.0% 3-H2BTB-4 4.0% Application Examples 2V2-HH-VFF(No.25) 20.0%1V-BHH-VFF(No.19) 10.0%V-BBH-VFF(No.9) 6.0%3-HB-C 10.0%1V2-BEB(F,F )-C 12.0% 3-HB-02 5.0% 3-HHB-1 10.0% 3-HHB-3 10.0% 3-HB(F)TB-2 5.0% 3-H2BTB-2 4.0% 3-H2BTB-3 4.0 %3-H2BTB-4 4.0% Application Example 31V-BHH-VFF(No.19) 4.0%1V2-BHH-VFF(No.118) 10.0%V2-HB-C 10.0%1V2-HB-C 10.0%3 -HB-C 26.0% 5-HB-C 12.0% 3-HB(F)-C 8.0% 2-BEB-C 3.0% V2-HHB-1 8.0% 3-H2BTB-2 3.0% 3-H2BTB-3 3.0% 3-H2BTB-4 3.0% Application example 4V2-HH-VFF(No.25) 9.0% 1V2-BEB(F, F)-C 11.0% 201-BEB(F)- C 5.0% 301-BEB(F)-C 9.0% 3-HB(F)-C 15.0% 101-HH-3 3.0% 4-BTB-02 9.0% 2-HHB(F)-C 13.0% 3-HHB (F)-C 14.0% 3-H2BTB-2 4.0%...
Embodiment 1
[0135] Preparation of 1-(2,2-difluorovinyl)-trans-4-(trans-4-(3-butenyl)cyclohexyl)cyclohexane Formula (1) compound, number 25, wherein A 3 and A 4 Is anti-1,4-cyclohexylene; Z 3 is a covalent bond; Q 1 and Q 2 is H; Q 3 and Q 4 is F; l, n, p and q are 0; and m is 2)
[0136] first step
[0137] A mixture of 165.6 g (463.6 mmol) of methyltriphenylphosphonium bromide and 1.5 liters of THF was cooled to -50°C under nitrogen flow. 57.2 g (509.8 mmol) t-BuOK was added to the mixture and stirred for 1 hour. A solution of 100.0 g (356.6 mmol) trans-4-(trans-4-(2-formylethyl)cyclohexyl)cyclohexanecarboxylate in 1 liter of THF was added dropwise to the mixture while maintaining the temperature at -50 below ℃. After the dropwise addition, the reaction temperature was gradually raised to room temperature, and stirred for another 5 hours. The solvent was distilled off under reduced pressure, then 500 ml of water was added, and the mixture was extracted with 500 ml of toluene. ...
Embodiment 2
[0146] Preparation of 1-(4,4-difluoro-3-butenyl)-trans-4-(trans-4-(trans-4-vinylcyclohexyl)cyclohexyl)cyclohexane (compound (6), Formula (1), where A 2 , A 3 and A 4 Is anti-1,4-cyclohexylene; Z 2 and Z 3 is a covalent bond; Q 1 and Q 2 is H; Q 3 and Q 4 is F; l, m and p are 0; q is 1; n is 2)
[0147] first step
[0148]A mixture of 128.1 g (358.6 mmol) of methyltriphenylphosphonium bromide and 1.5 liters of THF was cooled to -50°C under a stream of nitrogen. 44.3 g (394.8 mmol) t-BuOK was added to the mixture and stirred for 1 hour. To the mixture was added dropwise a solution of 100.0 g (275.8 mmol) methyl 2-(trans-4-(trans-4-(trans-4-formylcyclohexyl)cyclohexyl)cyclohexyl)ethanecarboxylate in 1 liter of THF , while keeping the temperature below -50°C. After the dropwise addition, the reaction temperature was gradually raised to room temperature, and stirred for another 5 hours. The solvent was distilled off under reduced pressure, then 500 ml of water was adde...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com